CASI Pharmaceuticals, Inc. (OTC:CASIF) People

CASI Pharmaceuticals, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Huang
Other companies: Connect Biopharma Holdings Limited (Founding Partner of Panacea Venture · Since at least Mar 18, 2026); Atara Biotherapeutics, Inc. (Human Capital · Since at least May 16, 2025); Orion Biotech Opportunities Corp (Chief Executive Officer, Director · May 12, 2021 – May 17, 2023 · Past); Alaunos Therapeutics, Inc. (Director · Jul 20, 2020 – Jun 6, 2023 · Past); Windtree Therapeutics, Inc. (Director · Dec 21, 2018 – Feb 22, 2023 · Past)
Director · Since at least Mar 18, 2026
Alexander A ZukiwskiGlobal Chief Medical Officer · Since at least Mar 18, 2026
Alex WuDirector · Since at least Nov 4, 2026
Chunhua WangChief Operating Officer · Since at least Mar 18, 2026
Frank SuDirector · Since at least Nov 4, 2026
Hai HuangGlobal Chief Commercial Ofcr · Since at least Mar 18, 2026
Junping ChenChief Medical Officer · Since at least Nov 5, 2026
Kun QianGlobal Controller · Since at least Mar 18, 2026
Thomas FolinsbeeDirector · Since at least Mar 18, 2026
Wei GaoGeneral Counsel · Since at least Nov 5, 2026
Wei-Wu HeExecutive Chairman · Since at least Nov 5, 2026
Xuebo ZengDirector · Since at least Mar 18, 2026